Research Tools

CellASIC Corp.

Brief Description

CellASIC¨ ONIX Microfluidic Platform delivers precise control for live cell analysis experiments by facilitating long-term perfusion cell culture. Cutting-edge microfluidics technology provides an improved cell culture microenvironment, exceptional quality for high magnification microscopy, and superior media switching capabilities.

The company was founded by UC Berkeley Professor of Bioengineering Luke Lee and his graduate students Paul Hung and Philip Lee.

Timeline 2004. Company founded 2012...

Research Tools

Vitrichoric, Inc.

Brief Description

Vitrichoric, Inc. develops technology for high-stability supercooling of aqueous solutions or suspensions for the preservation of biological matter.

Timeline 2021. Company founded Inventors

Gabriel Nastase, Boris Rubinsky, Gideon Ukpai

BioChoric

Brief Description

Biochoric uses isochoric supercooling to enable stable preservation of sensitive biological matter at sub-zero temperatures without freezing or solidification.

Timeline 2021. Company founded Inventors

Matthew Powell-Palm, Boris Rubinsky

Ventria Biosciences (formerly known as Applied Phytologics Inc.)

Brief Description

Ventria Bioscience is a privately held biopharmaceutical company with a product pipeline enabled by ExpressTec. ExpressTec is a patented, plant-based recombinant protein manufacturing technology that delivers a ten-fold higher recombinant protein yield than other plant-based systems. Ventria Bioscience's platform technology delivers meaningful and sustainable economic advantages by enabling new product opportunities that were not previously available. It can be used to develop new biotherapeutics, novel vaccines, reagents for biomanufacturing, and industrial and biofuel...

Vedere Bio II

Brief Description

Vedere Bio II is pioneering beyond traditional gene therapy to not just slow vision loss from inherited retinal degenerations (IRDs) or dry age-related macular degeneration (dry AMD) with geographic atrophy (GA), but actually restore it.

Timeline 2021. Vedere Bio II launches as the successor to the first Vedere Bio, which was acquired by Novartis in September 2020 Inventors

Matthew Banghart, Michael Hayden Berry, Katherine Borges, Johannes Broichhagen, John Flannery, Doris Fortin, Benjamin Gaub, Scott Franklin Geller, Pablo Gorostiza, Karen...

Tilden Bio

Brief Description

Development of photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins. The technology has been applied to enhance yields of high-value photosynthetic bioproducts in the UC Berkeley Melis Laboratory.

Formerly known as Tabletop Energy.

Timeline 2019. Company incorporated Inventors

Nico Betterle, Fiona Davies, Cinzia Formighieri, Diego Hidalgo Martinez, Henning Kirst, Andrew Saphire, Hsu Ching Wintz, Andreas Zurbriggen, Anastasios Melis

Tenaya Therapeutics

Brief Description

Tenaya Therapeutics is shaping the future of heart disease treatment driven by a mission to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. The company was founded by leading cardiology researchers at the Gladstone Institutes and UT Southwestern, and backed by a top-tier syndicate of investors.

Timeline 2016...

Texas Fluorescence Labs

Brief Description

Texas Fluorescence Labs was a reagent and assay technologies company, spun out of modern fluorescent calcium indicator discoveries at UC Berkeley. The company specialized in pioneering new approaches to ion channel and ion transporter-focused basic and translational research and provided reagents, assays, and assay development services to scientists, universities, and laboratories worldwide for research in biochemistry, biomolecular screening, microbiology, and neuroscience.

In 2018, UC Berkeley Professor of Chemistry and Biochemistry Roger Tsien shared the Nobel...

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...